SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/3B54A8AE3749B7B3F82FA822626691551B9B0EA08B1AE10309B26C9CE392B4D41A7A663BFECED73FCB026C581F12223C>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/3B54A8AE3749B7B3F82FA822626691551B9B0EA08B1AE10309B26C9CE392B4D41A7A663BFECED73FCB026C581F12223C
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/3B54A8AE3749B7B3F82FA822626691551B9B0EA08B1AE10309B26C9CE392B4D41A7A663BFECED73FCB026C581F12223C
http://www.w3.org/2000/01/rdf-schema#comment
"V3 isoform of versican interferes with CD44 and the CD44-EGFR/ErbB2 interaction altering the signaling pathways such as ERK1/2 and p38 MAPK that regulate cell proliferation and migration"
xsd:string
http://purl.uniprot.org/uniprot/#_02F00248A91B38567C65AF0A1B5A37EE3E7608A8507E88230133D26EFAF309D2F62A7A917724EF551BF3CE41787FC875
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/3B54A8AE3749B7B3F82FA822626691551B9B0EA08B1AE10309B26C9CE392B4D41A7A663BFECED73FCB026C581F12223C
http://purl.uniprot.org/uniprot/Q86W61
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/3B54A8AE3749B7B3F82FA822626691551B9B0EA08B1AE10309B26C9CE392B4D41A7A663BFECED73FCB026C581F12223C
http://purl.uniprot.org/uniprot/#_Q86W61-mappedCitation-21078678
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/3B54A8AE3749B7B3F82FA822626691551B9B0EA08B1AE10309B26C9CE392B4D41A7A663BFECED73FCB026C581F12223C